Table 1.
Number of isolates per antibiotic susceptibility profile stratified by source.
| Antibiotic Susceptibility Profiles | Farm (n = 170) | Transport (n = 19) | Abattoir (n = 77) | Total (n = 266) |
|---|---|---|---|---|
| Susceptible | 50 | 9 | 28 | 87 |
| AMP | 47 | 1 | 8 | 56 |
| AZM | 1 | 0 | 1 | 2 |
| CHL | 1 | 1 | 0 | 2 |
| CIP | 0 | 0 | 1 | 1 |
| GEN | 0 | 0 | 2 | 2 |
| LEX | 2 | 0 | 2 | 4 |
| NAL | 2 | 0 | 7 | 9 |
| SXT | 2 | 1 | 2 | 5 |
| TET | 33 | 4 | 1 | 38 |
| AMP-AMK | 1 | 0 | 0 | 1 |
| AMP-CHL | 3 | 0 | 0 | 3 |
| AMP-LEX | 2 | 0 | 1 | 3 |
| AMP-NAL | 2 | 1 | 0 | 3 |
| AMP-SXT | 0 | 0 | 1 | 1 |
| AMP-TET | 1 | 0 | 0 | 1 |
| LEX-TET | 1 | 0 | 0 | 1 |
| NAL-TET | 0 | 1 | 9 | 10 |
| SXT-CHL | 6 | 1 | 2 | 9 |
| TET-CHL | 1 | 0 | 0 | 1 |
| TET-GEN | 1 | 0 | 0 | 1 |
| TET-SXT | 1 | 0 | 4 | 5 |
| AMP-LEX-CHL | 1 | 0 | 0 | 1 |
| AMP-NAL-GEN | 0 | 0 | 1 | 1 |
| AMP-NAL-TET | 0 | 0 | 2 | 2 |
| AMP-TET-SXT | 1 | 0 | 2 | 3 |
| NAL-TET-SXT | 3 | 0 | 2 | 5 |
| AMP-TET-SXT-CHL | 2 | 0 | 0 | 2 |
| NAL-CIP-TET-SXT | 0 | 0 | 1 | 1 |
| AMP-CTX-TET-SXT-CHL | 1 | 0 | 0 | 1 |
| AMP-LEX-CRO-CTX-CHL | 1 | 0 | 0 | 1 |
| AMP-AMC-FOX-SXT-CHL-AMK | 1 | 0 | 0 | 1 |
| AMP-AMC-LEX-FOX-NAL-CIP | 1 | 0 | 0 | 1 |
| AMP-LEX-CRO-CTX-NAL-TET-CHL | 1 | 0 | 0 | 1 |
CRO, ceftriaxone; AZM, azithromycin; FOX, cefoxitin; FEP, cefepime; CTX, cefotaxime; AMK, amikacin; GEN, gentamicin; AMC, amoxycillin-clavulanic acid; CIP, ciprofloxacin; LEX, cefalexin; CHL, chloramphenicol; SXT, trimethoprim-sulfamethoxazole; NAL, nalidixic acid; TET, tetracycline; AMP, ampicillin.